The latest news and insights from Genoa Healthcare.
Tardive Dyskinesia (TD) – a neurological disorder associated with prolonged use of antipsychotic medications – affects over 600,000 people annually. Wondering what this means for the people you serve? Genoa...
Staying on top of new drug launches and shortages can be difficult. Read Genoa Healthcare’s latest drug trend report for an overview and connect with your local pharmacy team to...
1. Methadone and buprenorphine reduce risk of death after opioid overdose. (2018, June 19). NIH. 2. Methadone and buprenorphine reduce risk of death after opioid overdose. (2018, June 19). NIH....
1.Advancing pharmacological treatments for opioid use disorder (ADaPT-OUD). (2018, December 18). NIH. 2. Medications for substance use disorders (2023, February 21). SAMHSA. 3. Medications for substance use disorders (2023, February...
Staying on top of new drug launches and shortages can be difficult. Read Genoa Healthcare’s latest drug trend report for an overview and connect with your local pharmacy team to...
Learn more about this new treatment option for adults living with schizophrenia Genoa is here to help keep you informed on the latest in behavioral health medications. Read on to...
A study in the New England Journal of Medicine showed that pharmacies can offer a safe and accessible treatment starting point for patients with opioid use disorder and keep them...
Staying on top of new drug launches and shortages can be difficult. Read Genoa Healthcare’s latest drug trend report for an overview of the latest and connect with your local...
According to the CDC, flu season runs rampant from October through May.1 Looking to keep the people you serve safe during the 2023-2024 flu season? Keep these three trends on...
Genoa Healthcare’s latest drug trend report highlights information on new medication launches as well as noteworthy drug shortages currently in market. Brand name drug launches* Brixadi™ Zurzuvae™ (zuranolone) Generic drug...